13-108727495-A-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001198950.3(MYO16):ā€‹c.419A>Gā€‹(p.Asn140Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000088 in 1,614,032 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.00047 ( 0 hom., cov: 32)
Exomes š‘“: 0.000048 ( 0 hom. )

Consequence

MYO16
NM_001198950.3 missense

Scores

3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 5.08
Variant links:
Genes affected
MYO16 (HGNC:29822): (myosin XVI) This gene encodes an unconventional myosin protein. The encoded protein has been proposed to act as a serine/threonine phosphatase-1 targeting or regulatory subunit. Studies in a rat cell line suggest that this protein may regulate cell cycle progression. A variant within this gene may be associated with susceptibility to schizophrenia and elevated expression of this gene has been observed in the frontal cortex of human schizophrenia patients. [provided by RefSeq, Mar 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.022643507).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MYO16NM_001198950.3 linkuse as main transcriptc.419A>G p.Asn140Ser missense_variant 4/35 ENST00000457511.7 NP_001185879.1 F8W883

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MYO16ENST00000457511.7 linkuse as main transcriptc.419A>G p.Asn140Ser missense_variant 4/351 NM_001198950.3 ENSP00000401633.3 F8W883
MYO16ENST00000356711.7 linkuse as main transcriptc.353A>G p.Asn118Ser missense_variant 4/351 ENSP00000349145.2 Q9Y6X6-1
MYO16ENST00000251041.10 linkuse as main transcriptc.353A>G p.Asn118Ser missense_variant 4/255 ENSP00000251041.5 Q9Y6X6-3

Frequencies

GnomAD3 genomes
AF:
0.000473
AC:
72
AN:
152150
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00142
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000851
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000147
AC:
37
AN:
251268
Hom.:
0
AF XY:
0.000110
AC XY:
15
AN XY:
135790
show subpopulations
Gnomad AFR exome
AF:
0.00160
Gnomad AMR exome
AF:
0.000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.0000479
AC:
70
AN:
1461764
Hom.:
0
Cov.:
31
AF XY:
0.0000385
AC XY:
28
AN XY:
727196
show subpopulations
Gnomad4 AFR exome
AF:
0.00176
Gnomad4 AMR exome
AF:
0.000179
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000497
GnomAD4 genome
AF:
0.000473
AC:
72
AN:
152268
Hom.:
0
Cov.:
32
AF XY:
0.000457
AC XY:
34
AN XY:
74438
show subpopulations
Gnomad4 AFR
AF:
0.00142
Gnomad4 AMR
AF:
0.000850
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000833
Hom.:
0
Bravo
AF:
0.000559
ESP6500AA
AF:
0.00295
AC:
13
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000165
AC:
20

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 13, 2023The c.419A>G (p.N140S) alteration is located in exon 4 (coding exon 4) of the MYO16 gene. This alteration results from a A to G substitution at nucleotide position 419, causing the asparagine (N) at amino acid position 140 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0055
T;T;.;T
Eigen
Benign
0.014
Eigen_PC
Benign
0.10
FATHMM_MKL
Uncertain
0.94
D
M_CAP
Benign
0.068
D
MetaRNN
Benign
0.023
T;T;T;T
MetaSVM
Benign
-0.86
T
MutationAssessor
Benign
1.6
L;.;L;L
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-2.2
N;.;N;N
REVEL
Benign
0.16
Sift
Benign
0.085
T;.;T;T
Sift4G
Uncertain
0.0020
D;D;D;D
Polyphen
0.69
P;.;.;P
Vest4
0.21
MVP
0.59
MPC
0.42
ClinPred
0.060
T
GERP RS
4.7
Varity_R
0.096
gMVP
0.22

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs141525847; hg19: chr13-109379843; COSMIC: COSV51794509; API